LAB901 Ltd. partners with South Korean PCR diagnostics firm, Seegene Inc.
Lab901 Ltd. announced that it has signed a distribution deal with the Korean PCR diagnostics firm Seegene Inc. Under the deal, Lab901 has appointed Seegene as its exclusive diagnostics distributor for the ScreenTape® system in the Korean market. The parties will also co-market their ScreenTape® and Seeplex® products in the global multiplex PCR diagnostics market.
Richard Rowling, Lab901's Director of Sales & Marketing said "Lab901 is delighted to have secured this deal with Seegene. Combining Seegene's highly multiplexed PCR diagnostic kits with Lab901's simple and convenient automated analysis instrument will bring a great boost to both companies' global sales"
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement - Single-Molecule DNA Sequencing System Promises Dramatic Improvement in Cost, Speed, Versatility, and Simplicity of Sequencing
DESY X-ray lightsource identifies promising candidates for COVID drugs - Existing active substances bind to key virus protein
Merck KGaA to acquire all outstanding Millipore shares for US$ 107 per share in cash - Combination will create a € 2.1 billion (US$ 2.9 billion) partner for the Life Science sector and transform Merck Chemicals
A sub-femtosecond stop watch for 'photon finish' races
Silent carriers of malaria are unlikely to develop the disease